Literature DB >> 19937197

Proteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart.

Jun Wang1, Ling Bai, Jing Li, ChaoFeng Sun, Jin Zhao, ChangCong Cui, Ke Han, Yu Liu, XiaoZhen Zhuo, TingZhong Wang, Ping Liu, FenLing Fan, YouFei Guan, AiQun Ma.   

Abstract

This work characterizes the mitochondrial proteomic profile in the failing heart and elucidates the molecular basis of mitochondria in heart failure. Heart failure was induced in rats by myocardial infarction, and mitochondria were isolated from hearts by differential centrifugation. Using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry, a system biology approach was employed to investigate differences in mitochondrial proteins between normal and failing hearts. Mass spectrometry identified 27 proteins differentially expressed that involved in energy metabolism. Among those, the up-regulated proteins included tricarboxylic acid cycle enzymes and pyruvate dehydrogenase complex subunits while the down-regulated proteins were involved in fatty acid oxidation and the OXPHOS complex. These results suggest a substantial metabolic switch from free fatty acid oxidation to glycolysis in heart failure and provide molecular evidence for alterations in the structural and functional parameters of mitochondria that may contribute to cardiac dysfunction during ischemic injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937197     DOI: 10.1007/s11427-009-0140-2

Source DB:  PubMed          Journal:  Sci China C Life Sci        ISSN: 1006-9305


  12 in total

1.  Proteomic analysis of mitochondrial proteins in cardiomyocytes from rats subjected to intermittent hypoxia.

Authors:  Wei-Zhong Zhu; Xiu-Feng Wu; Yi Zhang; Zhao-Nian Zhou
Journal:  Eur J Appl Physiol       Date:  2011-07-07       Impact factor: 3.078

2.  Spatial distribution of cellular function: the partitioning of proteins between mitochondria and the nucleus in MCF7 breast cancer cells.

Authors:  Amal T Qattan; Marko Radulovic; Mark Crawford; Jasminka Godovac-Zimmermann
Journal:  J Proteome Res       Date:  2012-11-08       Impact factor: 4.466

Review 3.  Proteomic remodeling of mitochondria in heart failure.

Authors:  John M Hollander; Walter A Baseler; Erinne R Dabkowski
Journal:  Congest Heart Fail       Date:  2011-10-03

4.  Proteome reference map and regulation network of neonatal rat cardiomyocyte.

Authors:  Zi-jian Li; Ning Liu; Qi-de Han; You-yi Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-08-15       Impact factor: 6.150

5.  Translational medicine in China I: perspectives from Chinese physicians and scientists.

Authors:  Chengyu Jiang
Journal:  Sci China Life Sci       Date:  2012-01-07       Impact factor: 6.038

Review 6.  Role of microRNA in metabolic shift during heart failure.

Authors:  Mark V Pinti; Quincy A Hathaway; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-14       Impact factor: 4.733

7.  Mitochondrial NDUFS3 regulates the ROS-mediated onset of metabolic switch in transformed cells.

Authors:  Sonal Suhane; Hirotaka Kanzaki; Vaithilingaraja Arumugaswami; Ramachandran Murali; V Krishnan Ramanujan
Journal:  Biol Open       Date:  2013-01-17       Impact factor: 2.422

8.  Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders.

Authors:  Mithilesh Kumar Jha; Sangmin Jeon; Kyoungho Suk
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

9.  Serum Levels of Branched Chain Amino Acids Predict Duration of Cardiovascular Organ Failure in Septic Shock.

Authors:  Michael A Puskarich; Cora McHugh; Thomas L Flott; Alla Karnovsky; Alan E Jones; Kathleen A Stringer
Journal:  Shock       Date:  2021-07-01       Impact factor: 3.533

Review 10.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.